SPY332.11+2.05 0.62%
DIA272.00+3.59 1.34%
IXIC10,998.40+57.23 0.52%

Trxade Group Q2 EPS $(0.07) Misses $0.01 Estimate, Sales $6.60M Beat $2.15M Estimate

Trxade Group (NASDAQ:MEDS) reported quarterly losses of $(0.07) per share which missed the analyst consensus estimate of $0.01 by 800 percent. This is a 800 percent decrease over earnings of $0.01 per share from the same

Benzinga · -
Trxade Group (NASDAQ: MEDS) reported quarterly losses of $(0.07) per share which missed the analyst consensus estimate of $0.01 by 800 percent. This is a 800 percent decrease over earnings of $0.01 per share from the same period last year. The company reported quarterly sales of $6.60 million which beat the analyst consensus estimate of $2.15 million by 206.98 percent. This is a 247.37 percent increase over sales of $1.90 million the same period last year.